国际标准期刊号: 2475-7640

临床与实验移植杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Complications from Hematopoietic Stem Cell Transplantation that is not Infectious to the Lungs

Mathew Nicolson

A prominent cause of morbidity and mortality following hematopoietic stem cell transplant (HSCT) is pulmonary problems. Non-infectious pulmonary problems are becoming a major contributor to transplant-related mortality due to advancements in infection-related complications. Idiopathic pneumonia syndrome (IPS) and bronchiolitis obliterans syndrome (BOS) are the most common early and late consequences, respectively. They can be broadly categorised as either early or late problems. Results from earlier treatments, which mostly consisted of corticosteroids, were frequently poor, stressing the need for a deeper knowledge of the biology of the underlying diseases to direct the adoption of innovative medicines, which are now being used more frequently.